BI 3810944 / Boehringer Ingelheim - LARVOL DELTA

A Study in People With Advanced Cancer (Solid Tumours) to Test Different Doses of BI 3810944 and to Find Out Whether it Helps (clinicaltrials.gov) - P1 | N=69 | Recruiting | Sponsor: Boehringer Ingelheim | Not yet recruiting ➔ Recruiting

Enrollment open • First-in-human • Melanoma • Oncology • Solid Tumor • BRAF

1527-0001: A study in people with advanced cancer (solid tumours) to test different doses of BI 3810944 and to find out whether it helps (clinicaltrialsregister.eu) - P1 | N=26 | Not yet recruiting | Sponsor: Boehringer Ingelheim International GmbH

New P1 trial • Melanoma • Oncology • Solid Tumor

A Study in People With Advanced Cancer (Solid Tumours) to Test Different Doses of BI 3810944 and to Find Out Whether it Helps (clinicaltrials.gov) - P1 | N=75 | Not yet recruiting | Sponsor: Boehringer Ingelheim

First-in-human • New P1 trial • Melanoma • Oncology • Solid Tumor